In our survival analysis, we showed for the first time that low gene expression for MARC2, CUBN, and SLC47A1 and high gene expression of KRT17 were associated with poor overall survival of ccRCC patients. This evidence concerns the gene MTARC2 and nonpapillary renal cell carcinoma.